Image

Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact

Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact

Recruiting
All
Phase N/A

Powered by AI

Overview

In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.

Description

It has been reported that there is a difference in the degree of AD between the bladder and urinary tract motility tests, suggesting a potential difference according to the injection rate. According to Liu et al., the authors noted that stimulation of the urethra, prostate, and internal sphincter appears to induce AD more strongly than the injection rate. In addition, the two main factors contributing to AD among urinary kinetics tests are the patient's age and bladder maximum urination pressure. Considering these factors is important in preventing AD during urinary kinetics tests. Despite these previous studies, the prevalence and severity of AD according to the injection rate of urinary kinetics tests in SCI have not been quantitatively evaluated.

Eligibility

Inclusion Criteria:

  1. Patients with chronic spinal cord injury 6 months after receiving the award
  2. Patients with confirmed AD due to bladder fullness in previous urodynamic test
  3. Patients confirmed to have neurological damage level C1-T6, AIS A or B

Exclusion Criteria:

  1. Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test
  2. Patients who cannot undergo testing due to hemodynamic instability
  3. Patients who cannot undergo testing due to overt urinary tract infection

Study details
    Spinal Cord Injuries
    Autonomic Dysreflexia
    UDS Filling Speed

NCT06211491

Pusan National University Yangsan Hospital

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.